KOEDA Inc., Developing Next-Generation Anchor Stents Revolutionizing Endoscopic Treatment, Raises New Funds from Mitsubishi UFJ Capital
NQ Score
91/100
AI Summary (NQ-processed)
KOEDA Inc., a developer of next-generation endoscopic treatment devices using innovative "anchor technology," has secured new funding from Mitsubishi UFJ Capital, following additional investment from Tohoku University Venture Partners. This capital will accelerate domestic clinical trials and US market entry, aiming for an M&A exit by 2030.
AI analysis data is not yet available.